CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 38 filers reported holding CHEMBIO DIAGNOSTICS INC in Q1 2022. The put-call ratio across all filers is 2.81 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 354,670 | $887,000 | 0.55% |
| Newbridge Financial Services Group, Inc. | 61,675 | $154,000 | 0.10% |
| GAGNON SECURITIES LLC | 47,793 | $119,000 | 0.02% |
| Phocas Financial Corp. | 30,000 | $75,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 491,453 | $1,229,000 | 0.01% |
| SEGALL BRYANT & HAMILL, LLC | 701,318 | $1,754,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 179,680 | $449,000 | 0.01% |
| Jump Financial, LLC | 37,900 | $95,000 | 0.01% |
| Cutler Group LLC / CA | 44,918 | $112,000 | 0.01% |
| Virtu Financial LLC | 19,653 | $49,000 | 0.00% |